Life Sciences Research for Lifelong Health
lab photo hero

Krishnendu Chakraborty

Krish was awarded Ph.D. in Life Sciences from Jadavpur University, Kolkata, India in 2010. During his doctoral research he studied cancer mediated Immunosuppression and role of Neem leaf glycoprotein (NLGP) and Interferon alpha 2b as an immune modulator in the maintenance of immune homeostasis during head and neck squamous cell carcinoma (HNSCC). After finishing his doctoral thesis I joined Dept. of Pathobiological Sciences, Louisiana State University, USA and pursued his further research in the field of viral immunology. As a postdoctoral researcher he studied the role of immune modulatory cytokines in human metapneumo virus (hMPV) infection model. Presently he is working as a postdoctoral scientist in the Dept. of Lymphocyte Signalling Lab and Development, Babraham Institute, Cambridge, UK. His current interest is to determine the role of Phosphokinases and RNA binding proteins in Influenza virus infection.

Latest Publications

Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy.

Okkenhaug K, Graupera M, Vanhaesebroeck B

Cancer discovery
2159-8290: (2016)

PMID: 27655435

Ionic immune suppression within the tumour microenvironment limits T cell effector function.

Eil R, Vodnala SK, Clever D

537 1476-4687:539-543 (2016)

PMID: 27626381

PI3Kδ and primary immunodeficiencies.

Lucas CL, Chandra A, Nejentsev S

Nature reviews. Immunology
1474-1741: (2016)

PMID: 27616589

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

Coulter TI, Chandra A, Bacon CM

The Journal of allergy and clinical immunology
1097-6825: (2016)

PMID: 27555459

BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers.

Roychoudhuri R, Clever D, Li P

Nature immunology
1529-2916: (2016)

PMID: 27158840

The transcription factor BACH2 promotes tumor immunosuppression.

Roychoudhuri R, Eil RL, Clever D

The Journal of clinical investigation
1558-8238: (2016)

PMID: 26731475

Oncogenic PI3Kα promotes multipotency in breast epithelial cells.

Okkenhaug K, Roychoudhuri R

Science signaling
8 1937-9145:pe3 (2015)

PMID: 26535006

PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL).

Okkenhaug K, Burger JA

Current topics in microbiology and immunology
393 0070-217X:123-42 (2016)

PMID: 26350103

Editorial: Lipid Signaling in T Cell Development and Function.

Sauer K, Okkenhaug K

Frontiers in immunology
6 1664-3224:410 (2015)

PMID: 26322043